1. Rincon MY, Prada CE, Lopez M, Castillo V, Echeverria LE, Serrano N. Determination of Anti-Adeno-Associated Viral Vector Neutralizing Antibodies in Patients With Heart Failure in the Cardiovascular Foundation of Colombia (ANVIAS): Study Protocol. JMIR Res Protoc. 2016 Jun 9;5(2):e102 
    https://www.ncbi.nlm.nih.gov/pubmed/27282359
  2. Norma Serrano-Díaz, María C. Páez-Leal , María L. Luna-González, Elizabeth Guío-Mahecha Biobanks: critical tool for today’s biomedical research. Rev Univ Ind Santander Salud. 2016; 48(2): 97-117. 
    http://www.scielo.org.co/pdf/suis/v48n1/v48n1a13.pdf
  3. Serrano-Díaz N, Guío-Mahecha E, Páez-Leal MC. Informed Consent for Biobanks: An open ethical debate. Rev Univ Ind Santander Salud. 2016; 48(2): 246-256. 
    http://revistas.uis.edu.co/index.php/revistasaluduis/article/view/5513
  4. O’Rawe JA, Wu Y, Dörfel MJ, Rope AF, Au PY, Parboosingh JS, Moon S, Kousi M, Kosma K, Smith CS, Tzetis M, Schuette JL, Hufnagel RB, Prada CE, Martinez F0, Orellana C, Crain J, Caro-Llopis A, Oltra S, Monfort S, Jiménez-Barrón LT, Swensen J, Ellingwood S, Smith R, Fang H, Ospina S, Stegmann S, Den Hollander N, Mittelman D, Highnam G, Robison R, Yang E, Faivre L21, Roubertie A, Rivière JB, Monaan KG, Wang K, Davis EE, Katsanis N, Kalscheuer VM, Wang EH, Metcalfe K, Kleefstra T, Innes AM, Kitsiou-Tzeli S, Rosello M, Keegan CE, Lyon GJ. TAF1 Variants Are Associated with Dysmorphic Features, Intellectual Disability, and Neurological Manifestations. Am J Hum Genet. 2015 Dec 3;97(6):922-32. 
    https://www.ncbi.nlm.nih.gov/pubmed/26637982
  5. Prada CE, Hufnagel RB, Hummel TR, Lovell AM, Hopkin RJ, Saal HM, Schorry EK. The Use of Magnetic Resonance Imaging Screening for Optic Pathway Gliomas in Children with Neurofibromatosis Type 1. J Pediatr 2015 Oct; 167 (4): 851-856.e1. 
    http://www.ncbi.nlm.nih.gov/pubmed/26233602
  6. Rincon MY, VandenDriessche T, Chuah MK. Gene therapy for cardiovascular disease: advances in vector development, targeting, and delivery for clinical translation. Cardiovasc Res 2015 Oct 1; 108 (1): 4-20. 
    http://www.ncbi.nlm.nih.gov/pubmed/26239654
  7. Abrams AJ, Hufnagel RB, Rebelo A, Zanna C, Patel N, Gonzalez MA, Campeanu IJ, Griffin LB, Groenewald S, Strickland AV, Tao F, Speziani F, Abreu L, Schüle R, Caporali L, La Morgia C, Maresca A, Liguori R, Lodi R, Ahmed ZM, Sund KL, Wang X, Krueger LA, Peng Y, Prada CE, Prows CA, Schorry EK, Antonellis A, Zimmerman HH, Abdul-Rahman OA, Yang Y, Downes SM, Prince J, Fontanesi F, Barrientos A, Németh AH, Carelli V, Huang T, Zuchner S, Dallman JE5Mutations in SLC25A46, encoding a UGO1-like protein, cause an optic atrophy spectrum disorder. Nat Genet. 2015 Aug; 47 (8): 926-32. 
    http://www.ncbi.nlm.nih.gov/pubmed/26168012
  8. Wong D, Tortorelli S, Bishop L, Sellars EA, Schimmenti LA, Gallant N, Prada CE, Hopkin RJ, Leslie ND, Berry SA, Rosenblatt DS, Fair AL, Matern D, Raymond K, Oglesbee D, Rinaldo P, Gavrilov D. Outcomes of four patients with homocysteine remethylation disorders detected by newborn screening. Genet Med. 2016 Feb;18(2):162-7. 
    http://www.ncbi.nlm.nih.gov/pubmed/25856670
  9. Burrow TA, Sun Y, Prada CE, Bailey L, Zhang W, Brewer A, Wu SW, Setchell KD, Witte D, Cohen MB9, Grabowski GA. CNS, lung, and lymph node involvement in Gaucher disease type 3 after 11 years of therapy: clinical, histopathologic, and biochemical findings. Mol Genet Metab. 2015 Feb; 114 (2): 233-41. 
    http://www.ncbi.nlm.nih.gov/pubmed/25219293